The Impact of Managed Care on Access to Highly Active Antiretroviral Therapy and on Outcomes among Medicaid Beneficiaries with AIDS

Abstract

Medicaid has promoted managed care plans (MCPs) to control health care costs for HIV-infected enrollees. This article examines the impact of MCP enrollment on use of highly active antiretroviral therapy (HAART), antiretroviral therapy (ARV), hospitalization, and death among Medicaid beneficiaries with AIDS. A retrospective longitudinal cohort study of 7,028 Medicaid beneficiaries with AIDS in California was conducted from 1999 to 2001. The impact of MCP enrollment was estimated using single-equation and bivariate probit models. Baseline HAART use was found to be significantly lower for beneficiaries in MCPs versus fee-for-service (FFS). The effect was attenuated and not significant after correcting for selection bias. MCP enrollment was not associated with overall ARV use, mortality, or hospitalization. MCP enrollment does not substantially affect medication use or clinical outcomes. Before making changes to care delivery, policy makers should address the potential costs and benefits of MCP over FFS Medicaid for chronically ill beneficiaries.

Keywords

Medicaid managed care AIDS HIV HAART antiretroviral therapy

Get full access to this article

View all access options for this article.

References

Bartlett, J. G. 1997. Human immunodeficiency virus/AIDS Medicaid managed care network. Clinical Infectious Diseases 25 (4): 803-804.

Bartlett, J. G. , and R. Moore . 1999. A comprehensive plan for managed care of patients infected with human immunodeficiency virus. Clinical Infectious Diseases 29 (1): 50-55.

Bozzette, S. A. , S. H. Berry , N. Duan , M. R. Frankel , A. A. Leibowitz , D. Lefkowitz , C. A. Emmons , J. W. Senterfitt , M. L. Berk , S. C. Morton , and M. F. Shapiro . 1998. The care of HIV-infected adults in the United States. New England Journal of Medicine 339 (26): 1897-1904.

Bozzette, S. A. , G. Joyce , D. F. McCaffrey , A. A. Leibowitz , S. C. Morton , S. H. Berry , A. Rastegar , D. Timberlake , M. F. Shapiro , and D. P. Goldman 2001. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. New England Journal of Medicine 344 (11): 817-823.

Carpenter, C. C. , D. A. Cooper , M. A. Fischl , J. M. Gatell , B. G. Gazzard , S. M. Hammer , M. S. Hirsch , D. M. Jacobsen , D. A. Katzenstein , J. S. Montaner , D. D. Richman , M. S. Saag , M. Schechter , R. T. Schooley , M. A. Thompson , S. Vella , P. G. Yeni , and P. A. Volberding . 2000. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society—USA Panel. Journal of the American Medical Association 283 (3): 381-390.

Crystal, S. , U. Sambamoorthi , P. J. Moynihan , and E. McSpiritt . 2001. Initiation and continuation of newer antiretroviral treatments among Medicaid recipients with AIDS. Journal of General Internal Medicine 16 (12): 850-859.

D’Agostino, R. B. Jr. 1998. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine 17 (19): 2265-2281.

Department of Health Services . 2005. Updated Medi-Cal redesign fact sheet. Accessed August 11, 2005, at http://www.medi-calredesign.org/pdf/MC_Redesign_Fact_Sheet_11005_Final.pdf.

Donabedian, A. 1980. The definition of quality and approaches to its assessment, vol. 1. Ann Arbor, MI: Health Administration Press.

10.

Efron, B. , and R. Tibshirani . 1986. Bootstrap measures for standard errors, confidence intervals, and other measures of statistical accuracy. Statistical Science 1 (1): 54-77.

11.

Epstein, A. M. 1998. Rolling down the runway: The challenges ahead for quality report cards. Journal of the American Medical Association 279 (21): 1691-1696.

12.

Goldman, D. P. , and Y. Bao . 2004. Effective HIV treatment and the employment of HIV(+) adults. Health Services Research 39 (6 pt. 1): 1691-1712.

13.

Goldman, D. P. , J. Bhattacharya , A. A. Leibowitz , G. F. Joyce , M. F. Shapiro , and S. A. Bozzette . 2001. The impact of state policy on the costs of HIV infection. Medical Care Research and Review 58 (1): 31-53.

14.

Goldman, D. P. , J. Bhattacharya , D. F. McCaffrey , N. Duan , A. A. Leibowitz , G. F. Joyce , and S. C. Morton . 2001. Effect of insurance on mortality in an HIV-positive population in care. Journal of the American Statistical Association 96 (455): 883-894.

15.

Harris, K. M. , and D. K. Remler . 1998. Who is the marginal patient? Understanding instrumental variables estimates of treatment effects. Health Services Research 33 (5 pt. 1): 1337-1360.

16.

The Henry J. Kaiser Family Foundation . 2001. Medicaid’s role for persons with HIV/AIDS. The Henry J. Kaiser Family Foundation. Accessed January 21, 2002, at http://www.kff.org/hivaids/1588-index.cfm.

17.

Himmelstein, D. U. , S. Woolhandler , I. Hellander , and S. M. Wolfe . 1999. Quality of care in investor-owned vs not-for-profit HMOs. Journal of the American Medical Association 282 (2): 159-163.

18.

Kaiser Family Foundation . 2001. Medicaid and managed care [Fact Sheet] 2001. Accessed August 11, 2005, at http://www.kff.org/medicaid/2068b-index.cfm.

19.

Klein, J. 2005. A researcher’s guide to Medi-Cal, ed. M. C. S. Section . Sacramento, CA: California Department of Health Services.

20.

McClellan, M. , B. J. McNeil , and J. P. Newhouse . 1994. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. Journal of the American Medical Association 272 (11): 859-866.

21.

McCollum, G. , A. Livingston , K. Anklam , V. Orlich , and V. R. Vaid . 2003. California’s medical assistance program: Rate manual for two plan model. Sacramento, CA: Medi-Cal Managed Care Division Policy and Program Development Branch: Department of Health Services.

22.

Medi-Cal Policy Institute . 2000. Medi-Cal managed care. Medi-Cal Facts 8 (March 2000).

23.

Payne, S. M. , G. R. Seage 3rd , S. Oddleifson , K. Gallagher , M. vanBeuzekom , H. Losina , and T. Hertz . 1995. Using administratively collected hospital discharge data for AIDS surveillance. Annals of Epidemiology 5 (5): 337-346.

24.

Rawlings-Sekunda, J. 1999. Trends in serving people with HIV/AIDS through Medicaid managed care. Portland, ME: National Academy for State Health Policy.

25.

Rawlings-Sekunda, J. , and N. Kaye . 1998. Emerging practices and policy in Medicaid managed care for people with HIV/AIDS: Case studies of six programs. Portland, ME: National Academy for State Health Policy.

26.

Turner, B. J. , J. V. Kelly , and J. K. Ball . 1989. A severity classification system for AIDS hospitalizations. Medical Care 27 (4): 423-437.

27.

Yeni, P. G. , S. M. Hammer , C. C. Carpenter , D. A. Cooper , M. A. Fischl , J. M. Gatell , B. G. Gazzard , M. S. Hirsch , D. M. Jacobsen , D. A. Katzenstein , J. S. Montaner , D. D. Richman , M. S. Saag , M. Schechter , R. T. Schooley , M. A. Thompson , S. Vella , and P. A. Volberding . 2002. Antiretroviral treatment for adult HIV infection in 2002: Updated recommendations of the International AIDS Society-USA Panel. Journal of the American Medical Association 288 (2): 222-235.